News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
16,070 Results
Type
Article (272)
Company Profile (2)
Press Release (15796)
Section
Business (9355)
Career Advice (7)
Deals (1130)
Drug Development (1052)
Employer Resources (2)
FDA (184)
Job Trends (303)
News (11020)
Policy (359)
Tag
2027 Genetown Elite (1)
Academia (28)
Adcomms (1)
Allergies (1)
Alliances (482)
ALS (2)
Alzheimer's disease (55)
Antibody-drug conjugate (ADC) (4)
Approvals (189)
Artificial intelligence (7)
Autoimmune disease (2)
Bankruptcy (1)
Best Places to Work (287)
Biosimilars (2)
Biotechnology (1)
Bladder cancer (2)
Breast cancer (9)
Cancer (58)
Cardiovascular disease (3)
Career advice (7)
Career pathing (2)
Cell therapy (6)
Cervical cancer (1)
Clinical research (996)
Collaboration (8)
Compensation (11)
Complete response letters (1)
COVID-19 (13)
C-suite (3)
Cystic fibrosis (2)
Data (101)
Depression (2)
Diabetes (7)
Diagnostics (176)
Drug discovery (2)
Drug pricing (2)
Duchenne muscular dystrophy (4)
Earnings (9401)
Editorial (1)
Employer resources (1)
Events (1053)
Executive appointments (1)
FDA (323)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (10)
Gene editing (1)
Generative AI (1)
Gene therapy (8)
GLP-1 (45)
Government (29)
Guidances (119)
Healthcare (453)
IgA nephropathy (4)
Immunology and inflammation (7)
Immuno-oncology (1)
Indications (4)
Infectious disease (18)
Inflammatory bowel disease (2)
Influenza (3)
Intellectual property (3)
IPO (867)
Job creations (34)
Job search strategy (5)
JPM (2)
Labor market (1)
Layoffs (8)
Legal (54)
Lung cancer (13)
Lymphoma (9)
Management (1)
Manufacturing (3)
MASH (3)
Medical device (501)
Medtech (503)
Mergers & acquisitions (272)
Metabolic disorders (20)
Multiple sclerosis (2)
NASH (2)
Neurodegenerative disease (6)
Neuropsychiatric disorders (2)
Neuroscience (75)
NextGen: Class of 2026 (82)
Non-profit (25)
Obesity (7)
Opinion (1)
Ovarian cancer (4)
Pain (1)
Pancreatic cancer (1)
Parkinson's disease (4)
Partnered (1)
Patents (5)
Patient recruitment (3)
Peanut (1)
People (410)
Pharmaceutical (1)
Pharmacy benefit managers (1)
Phase 1 (211)
Phase 2 (403)
Phase 3 (424)
Pipeline (414)
Postmarket research (47)
Preclinical (62)
Psychedelics (1)
Radiopharmaceuticals (4)
Rare diseases (8)
Real estate (63)
Recruiting (1)
Regulatory (313)
Reports (2)
Research institute (33)
Rett syndrome (2)
RSV (1)
Schizophrenia (4)
Special edition (2)
Spinal muscular atrophy (2)
Sponsored (4)
Startups (25)
Vaccines (3)
Weight loss (2)
Women's health (2)
Date
Today (1)
Last 7 days (15)
Last 30 days (30)
Last 365 days (968)
2026 (34)
2025 (989)
2024 (1237)
2023 (1442)
2022 (1450)
2021 (1448)
2020 (1184)
2019 (879)
2018 (806)
2017 (640)
2016 (378)
2015 (570)
2014 (365)
2013 (190)
2012 (260)
2011 (304)
2010 (380)
Location
Africa (7)
Alabama (2)
Arizona (5)
Asia (873)
Australia (59)
California (306)
Canada (84)
China (24)
Colorado (18)
Connecticut (14)
Delaware (20)
Europe (1961)
Florida (63)
Georgia (12)
Illinois (34)
Indiana (27)
Japan (25)
Kansas (3)
Louisiana (6)
Maine (5)
Maryland (45)
Massachusetts (254)
Michigan (16)
Minnesota (34)
Missouri (3)
Montana (1)
Nevada (5)
New Hampshire (7)
New Jersey (93)
New York (78)
North Carolina (55)
Northern California (165)
Ohio (9)
Pennsylvania (95)
South America (17)
Southern California (117)
Tennessee (7)
Texas (33)
United States (1276)
Utah (12)
Virginia (2)
Washington State (33)
Wisconsin (2)
16,070 Results for "178".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
IPO
Metsera Seeks $289M Raise, $1.78B Valuation in IPO
The GLP-1 IPO arena has been heating up for the past two years and Metsera’s ask is one the largest in recent history.
January 27, 2025
·
1 min read
·
Dan Samorodnitsky
Basal Cell Carcinoma Treatment Market Size to Hit USD 17.8 Bn by 2030
According to Nova one advisor, the global Basal Cell Carcinoma Treatment market size is expected to hit around USD 17.8 billion by 2030 from valued at USD 8.75 billion in 2021 and growing at a CAGR of 10.1% from 2022 to 2030.
October 6, 2022
·
6 min read
Genetown
FogPharma Announces $178 Million Series D Financing to Advance Pipeline of First-in-Class Helicon Polypeptide Therapeutics Targeting Major Cancer Drivers
FogPharma®, a biopharmaceutical company pioneering a new class of precision medicines that could ultimately prove applicable to the vast majority of therapeutic targets, including those previously considered “undruggable,” today announced a $178 Million Series D financing.
November 21, 2022
·
6 min read
Biotech Bay
NIH Awards Contract to AN2 Therapeutics Valued Up to $17.8 MillionNIAID Agreement to Advance Development of Epetraborole for Acute Systemic Melioidosis
AN2 Therapeutics, Inc. today announced the award of a contract valued up to $17.8 million from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to advance the development of epetraborole for acute systemic melioidosis.
September 29, 2022
·
4 min read
Aytu BioPharma Ranked Number 178 Fastest-Growing Company in North America on the 2021 Deloitte Technology Fast 50(TM)
Aytu BioPharma, Inc. today announced it ranked 178 on the Deloitte Technology Fast 500.
November 17, 2021
·
3 min read
Policy
Siemens Awarded $1.78M FDA Contract to Showcase Advanced Digital Design and Manufacturing
The Food and Drug Administration’s Office of Counterterrorism and Emerging Threats has awarded a contract worth over $1.78M to Siemens Government Technologies with technology from Siemens Digital Industries.
October 1, 2021
·
6 min read
Molecular Biology Enzymes, Kits, and Reagents Market Report – Reach USD 41.10 Billion with 17.8% CAGR during (2022-2028)
The Insight Partners published latest research report on “Molecular Biology Enzymes, Kits, and Reagents Market Growth Report, Size, Share, Trends & Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, Application, and End User
May 16, 2023
·
7 min read
Drug Development
Silence Therapeutics Announces Positive Topline 48-Week Data from Phase 2 Study of Zerlasiran in Patients with Elevated Lipoprotein(a)
Silence Therapeutics plc today announced positive topline 48-week data from the ALPACAR-360 phase 2 study of zerlasiran (SLN360) in 178 subjects with baseline lipoprotein(a), or Lp(a), levels at or over 125 nmol/L at high risk of atherosclerotic cardiovascular disease (ASCVD) events.
June 20, 2024
·
5 min read
Recce Pharmaceuticals Receives AUD $11.17 Million Research and Development (R&D) Advance
Recce Pharmaceuticals Ltd announced it received AUD $11,178,965 as a research and development advance with Endpoints Capital, capturing Recce’s R&D tax incentive for the 2023/2024 fiscal year and 2025 fiscal year.
March 12, 2024
·
4 min read
Biotech Bay
TLC to Present Preclinical Data on TLC178 at ESMO 2019
TLC178 shows potential as a treatment for sarcomas, with enhanced efficacy, reduced toxicity and decreased dosing frequency
September 25, 2019
·
4 min read
1 of 1,607
Next
